Open AccessRetinoic Acid: A Potential Risk Factor for Congenital Heart Disease
Author(s) -
Maria Fareed Siddiqui,
Syed Muhammad Yousaf Farooq
Publication year - 2021
Publication title -
lgu journal of life sciences
Language(s) - English
Resource type - Journals
eISSN - 2521-0130
pISSN - 2519-9404
DOI - 10.54692/lgujls.2021.0503175
Subject(s) - retinoic acid , retinoid , medicine , pregnancy , heart disease , endocrinology , retinoic acid receptor , pharmacist , physiology , bioinformatics , biology , gene , biochemistry , genetics , family medicine , pharmacy
Retinoic acid (RA), a derivative of vitamin A, plays an essential role in human beings during growth and development. Intake of vitamin A in body is by eitheranimal/plant diet or use of medication to treat skin problems and cancer. Adequate intake of retinoic acid is critical as high and low quantities of retinoid lead todevelopmental defect by acting through retinoid receptors present in human body, which actively modulate many signaling pathways and control embryonic development and differentiation. Excess intake of RA cause congenital heart diseases (CHD) by up and down regulation of genes associated with CHD. Therefore, intake of retinoic acid or other analogous drugs especially during pregnancy enhances the risk of developing CHD. Physician and pharmacist should provide proper counseling to female patients about the benefits and risks of drugs prescribed during pregnancy. Furthermore, advancement in therapies likes surgery, angioplasty and tissue engineering used for the treatment of CHD. This review discusses an association between retinoic acid and CHD, its prevention and treatment options available.